Inflammatory Breast Cancer International Consortium
What is Inflammatory Breast Cancer (IBC)?
Inflammatory breast cancer is a rapidly progressing and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or inflamed.
Inflammatory breast cancer progresses rapidly, often in a matter of weeks or months. At diagnosis, inflammatory breast cancer is either stage III or IV disease, depending on whether cancer cells have spread only to nearby lymph nodes or to other tissues as well.
Learn more about IBC symptoms, diagnosis and treatment options. More >
About the Inflammatory Breast Cancer International Consortium (IBC-IC)
The Inflammatory Breast Cancer International Consortium (IBC-IC) was founded to foster collaboration among inflammatory breast cancer (IBC) researchers and clinicians.
The focus of our collaboration is to advance the leading research, education and information that will lead to the best outcomes and cures for IBC throughout the world. Our researchers and clinicians work at many of the leading cancer institutions worldwide.
Learn more about the IBC-IC’s mission, history and leadership. More >
Clinicians & Researchers
Affiliated researchers, scientists and clinicians committed to advancing the science and medicine of IBC to improve screening, early detection, treatment options and patient outcomes.Find an IBC clinician or researcher >
Leading cancer institutions focused on IBC advancing research, education and information that will lead to the best outcomes and cures for IBC throughout the world.Find an IBC center >